Cornell
Cornell University Spinout Inso Biosciences Sees Opportunity in Long-Read Sequencing Sample Prep
Premium
Inso is part of a wave of startups in the sequencing sample prep market that are looking to solve a bottleneck for all types of research.
Non-Western Populations Underrepresented in Microbiome Databases; Partnerships Could Boost Numbers
Premium
Recent analyses have underscored that populations outside North America and Europe are underrepresented in microbiome reference databases.
Eurofins Viracor Acquires Exclusive License to Cornell Cell-Free DNA Assay Technology
The company intends to use the technology to develop assays for monitoring tissue damage associated with COVID-19 infection and transplantation.
Expression, Microbiome Features Provide Pre-Treatment Lung Function Clues for Pediatric Patients
Researchers characterized microbial community and host expression features linked to impaired pulmonary function in children set to receive allogeneic hematopoietic cell transplants.
With bisulfite whole-genome sequencing of cfDNA from blood, researchers were able to monitor graft-versus-host disease, infection, graft failure, and disease relapse.